Oniria Therapeutics
Created in 2021
- BETA
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups Social networks
1,650Activities
Technologies
Entity types
Location
Centro Cellex, Centre Cellex, Centro Cellex, Carrer de Natzaret, 115, 117, 08035 Barcelona, Spain
Barcelona
Spain
Employees
Scale: 2-10
Estimated: 14
Engaged corporates
3
0 2Added in Motherbase
10 months, 3 weeks ago
biotech Value proposition
A shift in cancer treatment methodology makes a world of difference.
A shift in cancer treatment methodology makes a world of difference.
Oniria Therapeutics is a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA).
Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme.
Biotechnology, cancer, cell dormancy, first-in-class, biopharmaceutical, precision oncology, cancer persistence, Spin-off, Targeted therapy, and TET2
Home | Oniria Therapeutics
Modulating cell dormancy to overcome cancer persistence
https://www.oniriatherapeutics.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 HIPRA Animal Health | HIPRA Animal Health | Other 29 Jan 2024 | | |
 Dell Technologies Bank, Information Technology and Services | Dell Technologies Bank, Information Technology and Services | Other 30 Apr 2023 | | |
 Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 30 Apr 2023 | | |